Biocartis Group NV (EBR:BCART)
Belgium
· Delayed Price · Currency is EUR 0.2900
0.00 (0.00%)
At close: Aug 15, 2025, 5:30 PM CET
Biocartis Group NV Company Description
Biocartis Group NV does not have significant operations.
It was previously involved in the development and commercialization of molecular diagnostics solutions with a focus on oncology.
The company was incorporated in 2014 and is headquartered in Mechelen, Belgium.
Biocartis Group NV
| Country | Belgium |
| Founded | 2014 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 500 |
| CEO | Roger Moody |
Contact Details
Address: Generaal de Wittelaan 11 B Mechelen, 2800 Belgium | |
| Phone | 32 1 563 26 00 |
| Website | biocartisgroupnv.be |
Stock Details
| Ticker Symbol | BCART |
| Exchange | Euronext Brussels |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | BE0974281132 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Roger Moody | Chief Executive Officer |
| Piet Houwen | Chief Operating Officer |
| George A. Cardoza | Chief Financial Officer and Head of Service Delivery |
| Benoit Devogelaere | Chief Technology Officer |
| Geert Maertens Ph.D. | Chairman of Scientific Advisory Board and Chief Scientific Officer |
| Renate Degrave | Head of IR and Corporate Communications |
| Erik Vossenaar Ph.D. | Senior Vice-President of Corporate Development and Strategy |
| Susy Spruyt | Head of People and Organization |
| Dr. Erwin Sablon | Head of Research & Development and Alliance Management |
| Reginald Van Genechten | Head of Manufacturing and Supply Chain |